These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 19761379

  • 1. Mu opioid receptor from the zebrafish exhibits functional characteristics as those of mammalian mu opioid receptor.
    Marron Fdez de Velasco E, Law PY, Rodríguez RE.
    Zebrafish; 2009 Sep; 6(3):259-68. PubMed ID: 19761379
    [Abstract] [Full Text] [Related]

  • 2. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B, Hejnova L, Novotny J.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [Abstract] [Full Text] [Related]

  • 3. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
    Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1121-7. PubMed ID: 8819494
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H, Wang X, Wang J, Rothman RB.
    Synapse; 2004 Jun 01; 52(3):209-17. PubMed ID: 15065220
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm.
    Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW.
    Neuroscience; 2005 Jun 01; 133(1):209-20. PubMed ID: 15893644
    [Abstract] [Full Text] [Related]

  • 8. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR, Nahorski SR.
    Mol Pharmacol; 1995 Apr 01; 47(4):848-54. PubMed ID: 7723747
    [Abstract] [Full Text] [Related]

  • 9. ABIN-1 Negatively Regulates μ-Opioid Receptor Function.
    Zhou P, Jiang J, Yan H, Li Y, Zhao J, Wang X, Su R, Gong Z.
    Mol Pharmacol; 2018 Feb 01; 93(2):36-48. PubMed ID: 29237725
    [Abstract] [Full Text] [Related]

  • 10. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA, Navani DM, Yoburn BC.
    Pharmacol Biochem Behav; 2012 Mar 01; 101(1):155-65. PubMed ID: 22108651
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2001 Jul 01; 298(1):116-21. PubMed ID: 11408532
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.
    Wang YH, Sun JF, Tao YM, Xu XJ, Chi ZQ, Liu JG.
    Acta Pharmacol Sin; 2010 Apr 01; 31(4):393-8. PubMed ID: 20228826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
    Kumar K, Kumar S, Kurupati RK, Seth MK, Mohan A, Hussain ME, Pasha S.
    Eur J Pharmacol; 2011 Jan 10; 650(1):28-33. PubMed ID: 20887721
    [Abstract] [Full Text] [Related]

  • 16. G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.
    Burford NT, Wang D, Sadée W.
    Biochem J; 2000 Jun 15; 348 Pt 3(Pt 3):531-7. PubMed ID: 10839983
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL, Janvey AJ, Bolan E, Berezowska I, Nguyen TM, Schiller PW, Pasternak GW.
    J Pharmacol Exp Ther; 2003 Aug 15; 306(2):430-6. PubMed ID: 12663687
    [Abstract] [Full Text] [Related]

  • 19. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.
    Kersanté F, Moulédous L, Zajac JM, Mollereau C.
    Neurochem Int; 2010 Aug 15; 56(6-7):768-73. PubMed ID: 20211672
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA, Traynor JR.
    Brain Res; 2006 Feb 16; 1073-1074():290-6. PubMed ID: 16443205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.